Seroprevalence of Hepatitis A Virus Antibodies among the Patients with Chronic Hepatitis B in Turkey

Autor: Tuncer Ertem G, Sebnem Erdinc F, Cagla Sonmezer M, Temocin F, Ozsoy M, Necla Tulek, Moroglu C

Publikováno v: Euroasian Journal of Hepato-Gastroenterology

Background Hepatitis A virus (HAV) can cause significant pathology in patients with chronic hepatitis B virus (HBV), however, HAV can be prevented by vaccination. The aim of this study was to determine the implication of vaccination against HAV vacci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f2fea740cdc2d5883abdc5ea8e38eb
http://europepmc.org/articles/PMC5578535

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Seroprevalence of Hepatitis A Virus Antibodies among the Patients with Chronic Hepatitis B in Turkey.

Autor: Tulek N; Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey., Ozsoy M; Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey., Moroglu C; Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey., Cagla Sonmezer M; Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey., Temocin F; Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey., Tuncer Ertem G; Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey., Sebnem Erdinc F; Department of Infectious Diseases and Clinical Microbiology, Ankara Training and Research Hospital, Ankara, Turkey.

Publikováno v: Euroasian journal of hepato-gastroenterology [Euroasian J Hepatogastroenterol] 2015 Jul-Dec; Vol. 5 (2), pp. 95-97. Date of Electronic Publication: 2016 Jul 09.